Various multigene assays have been developed in an attempt to more accurately identify patients with ER+ breast cancer who will benefit from chemotherapy. Oncotype DX (Genomic Health, Redwood City, CA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback